Short-acting inhaled beta-2-agonists increased the mortality from chronic obstructive pulmonary disease in observational designs
To access this article, please choose from the options below
PII: S0895-4356(04)00195-7
doi:10.1016/j.jclinepi.2004.04.013
© 2005 Elsevier Inc. All rights reserved.
